Spine Top Stories OrthoPediatrics’ ApiFix® System Selected as 2022 MDEA Finalist byJosh SandbergApril 8, 2022
Spine OrthoPediatrics Surpasses Milestones of 500 Scoliosis Correction Cases Worldwide and Nine-Years of Clinical Experience with the ApiFix Procedure byChris StewartMarch 23, 2021
Spine OrthoPediatrics and ApiFix are committed to helping patients with adolescent idiopathic scoliosis and their families make informed decisions about treatment options byChris StewartFebruary 18, 2021
Spine OrthoPediatrics Corp. Commences Initial U.S. Launch of ApiFix’s FDA-Approved Spinal Deformity Correction System byChris StewartJune 10, 2020
Regulatory Spine ApiFix Receives FDA Approval to Commercialize MID-C System for Motion-Preserving Deformity Treatment of Progressive Idiopathic Scoliosis in Adolescents byJosh SandbergAugust 27, 2019
Financial Spine ApiFix Completes Financing to Prepare for Commercial Efforts in the United States byJosh SandbergApril 23, 2019
Spine ApiFix Surpasses 250 Scoliosis Patients Treated and Six-Year Follow-up of Earliest Cases byJosh SandbergOctober 2, 2018
Spine Top Stories ApiFix Signs Distribution Agreement in Canada; Completes First Cases in North America at IWK Health Centre Hospital, Halifax byJosh SandbergSeptember 5, 2017
Spine ApiFix® Reports “Substantial Reduction” of Scoliosis Curvature at One-to-Three Years Follow-up of 25 Patients Treated for Adolescent Idiopathic Scoliosis with Its Non-Fusion, Minimally Invasive Device byJosh SandbergJuly 14, 2015
